May 27, 2026 08:01AM
May 27, 2026 08:00AM
Apr 30, 2026 04:05PM
Feb 24, 2026 04:05PM
Jan 23, 2026 06:45AM
Jan 23, 2026 06:35AM
Jan 22, 2026 08:00AM Corcept's relacorilant meets survival endpoint in ovarian cancer trial
Jan 22, 2026 08:00AM
Jan 2, 2026 06:35AM
Jan 2, 2026 06:22AM
Dec 31, 2025 08:00AM
Dec 31, 2025 08:00AM
Nov 25, 2025 06:51AM
Nov 17, 2025 04:12PM Wolfe Research Starts Corcept Therapeutics (CORT) at Peerperform
Nov 4, 2025 04:05PM
Oct 19, 2025 05:15AM
Oct 14, 2025 08:00AM
Oct 14, 2025 08:00AM
Oct 6, 2025 08:53AM
Sep 22, 2025 02:32PM
Sep 22, 2025 02:30PM Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025
Sep 10, 2025 08:00AM
Sep 10, 2025 08:00AM
Jul 31, 2025 04:05PM
Jul 14, 2025 08:03AM
Jul 14, 2025 08:00AM
May 5, 2025 04:05PM
Mar 3, 2025 04:08PM Corcept Therapeutics (CORT): FDA Files New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
Mar 3, 2025 04:05PM
Aug 2, 2017 09:24AM
Sep 28, 2015 08:35AM
Sep 28, 2015 08:30AM

15,416 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All